Showing 201 - 220 results of 3,105 for search '"amyotrophic lateral sclerosis"', query time: 0.13s Refine Results
  1. 201
  2. 202

    The role of astrocytes with genetic mutations linked to amyotrophic lateral sclerosis by D. Brash-Arias, G.E. Aranda-Abreu, F. Rojas-Durán, M.E. Hernández-Aguilar, M.R. Toledo-Cárdenas, C.A. Pérez-Estudillo, A. Ortega, L.D. Chi-Castañeda

    Published 2023-04-01
    “…Despite advances in the understanding of genetic and molecular aspects of Amyotrophic Lateral Sclerosis (ALS), a rapidly progressive and fatal neurodegenerative disease, the exact pathogenic mechanisms are still largely unknown. …”
    Get full text
    Article
  3. 203
  4. 204

    The Link between VAPB Loss of Function and Amyotrophic Lateral Sclerosis by Nica Borgese, Nicola Iacomino, Sara Francesca Colombo, Francesca Navone

    Published 2021-07-01
    “…In 2004, it was discovered that a mutation (p.P56S) in the <i>VAPB</i> paralogue causes a rare form of dominantly inherited familial amyotrophic lateral sclerosis (ALS8). The mutant protein is aggregation-prone, non-functional and unstable, and its expression from a single allele appears to be insufficient to support toxic gain-of-function effects within motor neurons. …”
    Get full text
    Article
  5. 205
  6. 206
  7. 207
  8. 208
  9. 209

    Potential Diets to Improve Mitochondrial Activity in Amyotrophic Lateral Sclerosis by Sayuri Yoshikawa, Kurumi Taniguchi, Haruka Sawamura, Yuka Ikeda, Ai Tsuji, Satoru Matsuda

    Published 2022-12-01
    “…Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease, the pathogenesis of which is based on alternations in the mitochondria of motor neurons, causing their progressive death. …”
    Get full text
    Article
  10. 210

    MRI-Based Mapping of Cerebral Propagation in Amyotrophic Lateral Sclerosis by Hans-Peter Müller, Jan Kassubek

    Published 2018-09-01
    Subjects: “…amyotrophic lateral sclerosis…”
    Get full text
    Article
  11. 211

    Identification of Regulatory Factors and Prognostic Markers in Amyotrophic Lateral Sclerosis by Hualin Sun, Ming Li, Yanan Ji, Jianwei Zhu, Zehao Chen, Lilei Zhang, Chunyan Deng, Qiong Cheng, Wei Wang, Yuntian Shen, Dingding Shen

    Published 2022-02-01
    “…Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the progressive degeneration of motor neurons, leading to muscle atrophy, paralysis and even death. …”
    Get full text
    Article
  12. 212

    Behavior matters--cognitive predictors of survival in amyotrophic lateral sclerosis. by William T Hu, Matthew Shelnutt, Ashley Wilson, Nicole Yarab, Crystal Kelly, Murray Grossman, David J Libon, Jaffar Khan, James J Lah, Allan I Levey, Jonathan Glass

    Published 2013-01-01
    “…It is difficult to longitudinally characterize cognitive impairment in amyotrophic lateral sclerosis (ALS) due to motor deficits, and existing instruments aren't comparable with assessments in other dementias.The ALS Brief Cognitive Assessment (ALS-BCA) was validated in 70 subjects (37 with ALS) who also underwent detailed neuropsychological analysis. …”
    Get full text
    Article
  13. 213
  14. 214

    The preferences of people with amyotrophic lateral sclerosis on riluzole treatment in Europe by Albert C. Ludolph, Harish Grandjean, Evy Reviers, Valentina De Micheli, Cosetta Bianchi, Leonardo Cardosi, Hermann Russ, Vincenzo Silani

    Published 2023-12-01
    “…Abstract The Patient Preference Survey aims to understand unmet needs related to riluzole management in people with Amyotrophic Lateral Sclerosis (ALS) and to identify which characteristics of a new formulation could better match their preferences. …”
    Get full text
    Article
  15. 215

    Sleep disorders of insomnia type in patients with amyotrophic lateral sclerosis by G. N. Levitskiy, M. G. Poluektov

    Published 2017-11-01
    “…Objective: to evaluate the rate of sleep disorders of insomnia type among patients with amyotrophic lateral sclerosis (ALS) and to study the connection between these disorders and clinical characteristics of the disease. …”
    Get full text
    Article
  16. 216

    Dextromethorphan/quinidine for the treatment of bulbar impairment in amyotrophic lateral sclerosis by Lauren Tabor Gray, Eduardo Locatelli, Terrie Vasilopoulos, James Wymer, Emily K. Plowman

    Published 2023-08-01
    “…Abstract Objective No efficacious treatments exist to improve or prolong bulbar functions of speech and swallowing in persons with amyotrophic lateral sclerosis (pALS). This study evaluated the short‐term impact of dextromethorphan/quinidine (DMQ) treatment on speech and swallowing function in pALS. …”
    Get full text
    Article
  17. 217
  18. 218
  19. 219
  20. 220

    Efficacy of transdermal scopolamine for sialorrhea in patients with amyotrophic lateral sclerosis by Kiyomi Odachi, Yugo Narita, Yuka Machino, Tomomi Yamada, Yuki Nishimura, Yasuyuki Ota, Satoshi Tamaru, Hidekazu Tomimoto

    Published 2017-01-01
    “…Background: Sialorrhea, the excessive flow of saliva from the mouth, causes distress in about half of patients with amyotrophic lateral sclerosis (ALS). Treatments of sialorrhea in ALS include systemic anticholinergic drugs, amitriptyline, botulinum toxin injection, and salivary gland radiotherapy, although each has limitations. …”
    Get full text
    Article